AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/368
IMMUNOTHERAPY FOR CHRONIC MYELOID-LEUKEMIA
Authors: APPERLEY JF DAZZI F CRADDOCK C GOLDMAN JM
Citation: Jf. Apperley et al., IMMUNOTHERAPY FOR CHRONIC MYELOID-LEUKEMIA, HEM CELL TH, 40(5), 1998, pp. 229-232
MUTATION DETECTION AND TYPING OF POLYMORPHIC LOCI THROUGH DOUBLE-STRAND CONFORMATION ANALYSIS
Authors: ARGUELLO JR LITTLE AM PAY AL GALLARDO D ROJAS I MARSH SGE GOLDMAN JM MADRIGAL JA
Citation: Jr. Arguello et al., MUTATION DETECTION AND TYPING OF POLYMORPHIC LOCI THROUGH DOUBLE-STRAND CONFORMATION ANALYSIS, Nature genetics, 18(2), 1998, pp. 192-194
A 2-COLOR BCR-ABL PROBE THAT GREATLY REDUCES THE FALSE-POSITIVE AND FALSE-NEGATIVE RATES FOR FLUORESCENCE IN-SITU HYBRIDIZATION IN CHRONIC MYELOID-LEUKEMIA
Authors: GRAND FH CHASE A IQBAL S NGUYEN DX LEWIS JL MARLEY SB DAVIDSON RJ GOLDMAN JM GORDON MY
Citation: Fh. Grand et al., A 2-COLOR BCR-ABL PROBE THAT GREATLY REDUCES THE FALSE-POSITIVE AND FALSE-NEGATIVE RATES FOR FLUORESCENCE IN-SITU HYBRIDIZATION IN CHRONIC MYELOID-LEUKEMIA, Genes, chromosomes & cancer, 23(2), 1998, pp. 109-115
INTERLEUKIN-3 (IL-3), BUT NOT STEM-CELL FACTOR (SCF) INCREASES SELF-RENEWAL BY HUMAN ERYTHROID BURST-FORMING UNITS (BFU-E) IN-VITRO
Authors: LEWIS JL MARLEY SB BLACKETT NM SZYDLO R GOLDMAN JM GORDON MY
Citation: Jl. Lewis et al., INTERLEUKIN-3 (IL-3), BUT NOT STEM-CELL FACTOR (SCF) INCREASES SELF-RENEWAL BY HUMAN ERYTHROID BURST-FORMING UNITS (BFU-E) IN-VITRO, Cytokine, 10(1), 1998, pp. 49-54
COST-EFFECTIVENESS OF INTERFERON-ALPHA FOR CHRONIC MYELOID-LEUKEMIA
Authors: GOLDMAN JM
Citation: Jm. Goldman, COST-EFFECTIVENESS OF INTERFERON-ALPHA FOR CHRONIC MYELOID-LEUKEMIA, Annals of oncology, 9(4), 1998, pp. 351-352
SCREENING AND JUSTIFICATION FOR PROPHYLACTIC INTERVENTION IN FAILING HEMODIALYSIS GRAFTS AND FISTULAS
Authors: SULLIVAN KL GOLDMAN JM
Citation: Kl. Sullivan et Jm. Goldman, SCREENING AND JUSTIFICATION FOR PROPHYLACTIC INTERVENTION IN FAILING HEMODIALYSIS GRAFTS AND FISTULAS, Seminars in dialysis, 11(6), 1998, pp. 347-350
ASSIGNMENT OF THE STEROID-RECEPTOR COACTIVATOR-1 (SRC-1) GENE TO HUMAN-CHROMOSOME BAND 2P23
Authors: CARAPETI M AGUIAR RCT CHASE A GOLDMAN JM CROSS NCP
Citation: M. Carapeti et al., ASSIGNMENT OF THE STEROID-RECEPTOR COACTIVATOR-1 (SRC-1) GENE TO HUMAN-CHROMOSOME BAND 2P23, Genomics (San Diego, Calif.), 52(2), 1998, pp. 242-244
DISCORDANT ERYTHROPOIESIS IN CML
Authors: MARLEY SB LEWIS JL GOLDMAN JM GORDON MY
Citation: Sb. Marley et al., DISCORDANT ERYTHROPOIESIS IN CML, Leukemia, 12(3), 1998, pp. 444-444
CD34-MEDIATED HOMOTYPIC ADHESION AND REGULATION OF PRIMARY HEMATOPOIETIC PROGENITOR CELLS
Authors: GORDON MY MARLEY SB DAVIDSON RJ GRAND FH ROBERTSON D GOLDMAN JM
Citation: My. Gordon et al., CD34-MEDIATED HOMOTYPIC ADHESION AND REGULATION OF PRIMARY HEMATOPOIETIC PROGENITOR CELLS, Experimental hematology, 26(8), 1998, pp. 54-54
A HIGH-RESOLUTION HLA CLASS-I AND CLASS-II MATCHING METHOD FOR BONE-MARROW DONOR SELECTION
Authors: ARGUELLO JR LITTLE AM BOHAN E GALLARDO D OSHEA J DODI IA GOLDMAN JM MADRIGAL JA
Citation: Jr. Arguello et al., A HIGH-RESOLUTION HLA CLASS-I AND CLASS-II MATCHING METHOD FOR BONE-MARROW DONOR SELECTION, Bone marrow transplantation, 22(6), 1998, pp. 527-534
DONOR-DERIVED PLASMODIUM-VIVAX INFECTION FOLLOWING VOLUNTEER UNRELATED BONE-MARROW TRANSPLANTATION
Authors: ODONNELL J GOLDMAN JM WAGNER K EHINGER G MARTIN N LEAHY M KARIUKI N ROBERTS I
Citation: J. Odonnell et al., DONOR-DERIVED PLASMODIUM-VIVAX INFECTION FOLLOWING VOLUNTEER UNRELATED BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 21(3), 1998, pp. 313-314
USE OF G-CSF TO MOBILIZE PBSC IN NORMAL HEALTHY DONORS - AN INTERNATIONAL SURVEY
Authors: CLEAVER SA GOLDMAN JM
Citation: Sa. Cleaver et Jm. Goldman, USE OF G-CSF TO MOBILIZE PBSC IN NORMAL HEALTHY DONORS - AN INTERNATIONAL SURVEY, Bone marrow transplantation, 21, 1998, pp. 29-31
ADOPTIVE IMMUNOTHERAPY FOR RELAPSE OF CHRONIC MYELOID-LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANT - EQUAL EFFICACY OF LYMPHOCYTES FROMSIBLING AND MATCHED UNRELATED DONORS
Authors: VANRHEE F SAVAGE D BLACKWELL J ORCHARD K DAZZI F LIN F CHASE A BUNGEY J CROSS NCP APPERLEY J SZYDLO R GOLDMAN JM
Citation: F. Vanrhee et al., ADOPTIVE IMMUNOTHERAPY FOR RELAPSE OF CHRONIC MYELOID-LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANT - EQUAL EFFICACY OF LYMPHOCYTES FROMSIBLING AND MATCHED UNRELATED DONORS, Bone marrow transplantation, 21(10), 1998, pp. 1055-1061
ALLOGENEIC AND AUTOLOGOUS TRANSPLANTATION FOR HEMATOLOGICAL DISEASES,SOLID TUMORS AND IMMUNE DISORDERS - CURRENT PRACTICE IN EUROPE IN 1998
Authors: GOLDMAN JM SCHMITZ N NIETHAMMER D GRATWOHL A
Citation: Jm. Goldman et al., ALLOGENEIC AND AUTOLOGOUS TRANSPLANTATION FOR HEMATOLOGICAL DISEASES,SOLID TUMORS AND IMMUNE DISORDERS - CURRENT PRACTICE IN EUROPE IN 1998, Bone marrow transplantation, 21(1), 1998, pp. 1-7
TRENDS IN UK UNRELATED DONOR SEARCHES 1991-1997
Authors: CLEAVER SA HARTWELL L GOLDMAN JM
Citation: Sa. Cleaver et al., TRENDS IN UK UNRELATED DONOR SEARCHES 1991-1997, Bone marrow transplantation, 21, 1998, pp. 95-95
HIGH-RESOLUTION HLA MATCHING AND CORRELATION WITH CLINICAL OUTCOME INUNRELATED DONOR BMT
Authors: OSHEA J SCOTT I BOHAN E FIRMAN H CLEAVER S JAMISON J MORLAND AD GOLDMAN JM MADRIGAL JA
Citation: J. Oshea et al., HIGH-RESOLUTION HLA MATCHING AND CORRELATION WITH CLINICAL OUTCOME INUNRELATED DONOR BMT, Bone marrow transplantation, 21, 1998, pp. 99-99
HIDDEN HLA MISMATCHES IN UNRELATED BONE-MARROW TRANSPLANTATION
Authors: PAY AL LITTLE AM ARGUELLOASTORGA R PRENTICE HG GOLDMAN JM MADRIGAL JA
Citation: Al. Pay et al., HIDDEN HLA MISMATCHES IN UNRELATED BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 115-115
IMPACT OF RECIPIENT CMV STATUS ON OUTCOME AFTER T-DEPLETED VUD TRANSPLANTATION FOR CML
Authors: CRADDOCK C SZYDLO RM WARD K YONG A KANFER E APPERLEY J GOLDMAN JM
Citation: C. Craddock et al., IMPACT OF RECIPIENT CMV STATUS ON OUTCOME AFTER T-DEPLETED VUD TRANSPLANTATION FOR CML, Bone marrow transplantation, 21, 1998, pp. 120-120
DONOR LYMPHOCYTE INFUSIONS FACILITATED BY THE ANTHONY-NOLAN-BONE-MARROW-TRUST - INCIDENCE AND CLINICAL OUTCOME
Authors: CLEAVER SA JAMISON J HARTWELL L GOLDMAN JM
Citation: Sa. Cleaver et al., DONOR LYMPHOCYTE INFUSIONS FACILITATED BY THE ANTHONY-NOLAN-BONE-MARROW-TRUST - INCIDENCE AND CLINICAL OUTCOME, Bone marrow transplantation, 21, 1998, pp. 230-230
ANALYSIS OF TCR V(BETA) USAGE IN T-CELL LINES SHOWING SPECIFICITY FORAUTOLOGOUS LEUKEMIC-CELLS GENERATED FROM A PATIENT RECEIVING DLT FOR RELAPSE FOLLOWING BMT IA
Authors: DODI IA VANRHEE F ROURAMIR C FORDE H FISCHER G JARAQUEMADA D GOLDMAN JM MADRIGAL JA
Citation: Ia. Dodi et al., ANALYSIS OF TCR V(BETA) USAGE IN T-CELL LINES SHOWING SPECIFICITY FORAUTOLOGOUS LEUKEMIC-CELLS GENERATED FROM A PATIENT RECEIVING DLT FOR RELAPSE FOLLOWING BMT IA, Bone marrow transplantation, 21, 1998, pp. 234-234
DONOR LYMPHOCYTE INFUSION (DLI) FOR RELAPSE OF CML AFTER ALLO-BMT - COMPARISON OF 2 REGIMENS
Authors: DAZZI F RAANANI P VANRHEE F SZYDLO R OLAVARRIA E KAEDA J APPERLEY JF CROSS NCP GOLDMAN JM
Citation: F. Dazzi et al., DONOR LYMPHOCYTE INFUSION (DLI) FOR RELAPSE OF CML AFTER ALLO-BMT - COMPARISON OF 2 REGIMENS, Bone marrow transplantation, 21, 1998, pp. 250-250
ESCALATING DOSES OF DLI IDENTIFY A SUBSET OF CML PATIENTS IN RELAPSE AFTER ALLOGRAFTING IN WHOM ONLY A PARTIAL OR TRANSIENT-RESPONSE IS ACHIEVED
Authors: KAEDA JS DAZZI F BAKER P RAANANI P KANFER E APPERLEY JF CROSS NCP GOLDMAN JM
Citation: Js. Kaeda et al., ESCALATING DOSES OF DLI IDENTIFY A SUBSET OF CML PATIENTS IN RELAPSE AFTER ALLOGRAFTING IN WHOM ONLY A PARTIAL OR TRANSIENT-RESPONSE IS ACHIEVED, Bone marrow transplantation, 21, 1998, pp. 251-251
BMT FOR CHRONIC MYELOID-LEUKEMIA (CML) - A MULTIVARIATE STUDY TO DETERMINE PROGNOSTIC FACTORS FOR SURVIVAL BEYOND THE FIRST YEAR
Authors: SZYDLO RM SAVAGE DG GOLDMAN JM
Citation: Rm. Szydlo et al., BMT FOR CHRONIC MYELOID-LEUKEMIA (CML) - A MULTIVARIATE STUDY TO DETERMINE PROGNOSTIC FACTORS FOR SURVIVAL BEYOND THE FIRST YEAR, Bone marrow transplantation, 21, 1998, pp. 301-301
CYTOGENETIC STATUS PRETRANSPLANT AS A PREDICTOR OF OUTCOME POST BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOGENOUS LEUKEMIA (CML)
Authors: KONSTANTINIDOU P SZYDLO RM CHASE A GOLDMAN JM
Citation: P. Konstantinidou et al., CYTOGENETIC STATUS PRETRANSPLANT AS A PREDICTOR OF OUTCOME POST BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOGENOUS LEUKEMIA (CML), Bone marrow transplantation, 21, 1998, pp. 302-302
TRANSPLANT-RELATED MORTALITY (TRM) FOLLOWING ALLOGENEIC BMT FOR CHRONIC MYELOID-LEUKEMIA (CML) PATIENTS AGED OVER 45
Authors: CAPELLI D SZYDLO RM SAVAGE DG APPERLEY J GOLDMAN JM
Citation: D. Capelli et al., TRANSPLANT-RELATED MORTALITY (TRM) FOLLOWING ALLOGENEIC BMT FOR CHRONIC MYELOID-LEUKEMIA (CML) PATIENTS AGED OVER 45, Bone marrow transplantation, 21, 1998, pp. 303-303
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>